Author

D. Papadopoulou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:ATAC-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Tzaferis· 2 shared F. Roumelioti· 2 shared G. Kollias· 2 shared M. Denis· 2 shared N. Karagianni· 2 shared P. Chouvardas· 2 shared A. Andrikos· 1 shared A. Liakos· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

C. Tzaferis

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintAug 2, 2022

Repurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts activation in arthritis.

D. Papadopoulou, F. Roumelioti, C. Tzaferis…·G. Kollias

This study identifies Amisulpride as a potential therapeutic for arthritis by reducing synovial fibroblast activation, independent of its known targets.

DOI 10.1101/2022.08.02.500956

mouseproteomics

𝕏 PostBluesky

Cell BiologybioRxivPreprintJul 22, 2022

miR-221/222 drive synovial fibroblast expansion and pathogenesis of TNF-mediated arthritis

F. Roumelioti, C. Tzaferis, D. Konstantopoulos…·G. Kollias

This study shows miR-221/222 promotes synovial fibroblast expansion and worsens TNF-mediated arthritis by regulating cell cycle and ECM pathways.

DOI 10.1101/2022.07.22.500939

mouseATAC-seq

𝕏 PostBluesky

ImmunologybioRxivMay 8, 2019

Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy

M. Stangou, S. Marinaki, E. Papachristou…·A. Papagianni

This study compares long-term outcomes of Cyclophosphamide and Calcineurin inhibitors in Primary Membranous Nephropathy, finding Cyclophosphamide associated with better renal function preservation and lower relapse rates.

DOI 10.1371/journal.pone.0217116

human

𝕏 PostBluesky